COMPANION MEETINGS Rodger C. Haggitt Gastrointestinal Pathology Society   Sunday, February 27, 2011 — 1:30 p.m.   CC BRA Evolving Concepts in Pancreatic Pathology   Moderator: Rhonda K. Yantiss, Weill Medical College of Cornell University, New York, NY   Disclosure: In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Symposium) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. The speakers listed below have indicated they have nothing to disclose. Click the button above to add this event to your Itinerary Planner... 1:30 Autoimmune Pancreatitis: Not Just the Pancreas - Thomas C. Smyrk, Mayo Clinic, Rochester, MN 2:00 Update on Diagnostic Features and Terminology of Cystic Pancreatic Tumors - N. Volkan Adsay, Emory University Hospital, Atlanta, GA 2:30 Classification, Grading and Staging of Pancreatic Neuroendocrine Tumors - David S. Klimstra, Memorial Sloan- Kettering Cancer Center, New York, NY 3:00 Coffee Break 3:30 Pancreatic Cytopathology: Practical Points to Avoid Common Pitfalls - Barbara A. Centeno, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 4:00 RODGER C. HAGGITT MEMORIAL LECTURE: Genes to the Microscope: Pancreatic Pathology in the Era of Whole Genome Sequencing - Ralph H. Hruban, The Johns Hopkins University School of Medicine, Baltimore, MD Members of the Rodger C. Haggitt Gastrointestinal Pathology Society Education Committee felt a discussion of pancreatic pathology to be timely. Several recent advances in the study of pancreatic disorders have impacted the preoperative diagnosis and post-surgical management of patients with these diseases. Improved imaging techniques have led to increased detection of early-stage carcinomas amenable to surgical resection, as well as discovery of incidental pancreatic cysts that may be clinically followed. Unfortunately, pathologists face a variety of challenges in the pre-operative evaluation of these lesions, particularly with respect to fine needle aspiration biopsy samples. Advances in our understanding of immunology have led to recognition of specific subtypes of immune-mediated pancreatic injury, changing the way we diagnose and treat patients with pancreatitis. The past few years have also seen the emergence of tumor classification schemes and staging criteria for pancreatic neoplasms and increased use of molecular techniques in the evaluation of patients with these tumors.